Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30,000
Closed -$2.27M 4536
2023
Q1
$2.27M Sell
30,000
-30,000
-50% -$2.3M ﹤0.01% 2606
2022
Q4
$4.64M Buy
+60,000
New +$4.64M 0.01% 2170
2015
Q1
Sell
-20,000
Closed -$1.11M 3986
2014
Q4
$1.11M Sell
20,000
-20,000
-50% -$1.09M ﹤0.01% 2750
2014
Q3
$2.11M Hold
40,000
﹤0.01% 2200
2014
Q2
$2.09M Sell
40,000
-47,400
-54% -$2.35M ﹤0.01% 2268
2014
Q1
$4.23M Sell
87,400
-169,200
-66% -$7.87M 0.01% 1718
2013
Q4
$11.5M Sell
256,600
-66,400
-21% -$2.95M 0.02% 1036
2013
Q3
$13.8M Buy
323,000
+39,200
+14% +$1.67M 0.02% 788
2013
Q2
$11.6M Buy
+283,800
New +$11.6M 0.02% 793

Other funds holding SRE

David Shaw's SRE Position: Q2 2026 in Review

David Shaw sold out of Sempra (SRE) in Q2 2026, closing a stake of 672,770 shares — an estimated $65.4M sold.

David Shaw first reported a position in SRE in Q2 2013 and held it in 46 quarters. The position peaked at $142M in Q1 2020. 1,280 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • David Shaw reported no remaining Sempra position as of Q2 2026 after selling out during the quarter.
  • David Shaw sold 672,770 Sempra shares in Q2 2026, an estimated $65.4M.
  • David Shaw first reported a position in Sempra in Q2 2013 and held it in 46 quarters.
  • David Shaw's Sempra position peaked at $142M in Q1 2020.
  • 1,280 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.